SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001559053-16-000074
Filing Date
2016-08-02
Accepted
2016-08-02 17:01:09
Documents
59
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q prta2016q210-q.htm 10-Q 936037
2 EXHIBIT 31.1 prta2016q210-qxex311.htm EX-31.1 14394
3 EXHIBIT 31.2 prta2016q210-qxex312.htm EX-31.2 14460
4 EXHIBIT 32.1 prta2016q210-qxex321.htm EX-32.1 14633
  Complete submission text file 0001559053-16-000074.txt   4197881

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT prta-20160630.xml EX-101.INS 624663
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prta-20160630.xsd EX-101.SCH 45762
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prta-20160630_cal.xml EX-101.CAL 69705
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prta-20160630_def.xml EX-101.DEF 178308
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prta-20160630_lab.xml EX-101.LAB 516063
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prta-20160630_pre.xml EX-101.PRE 281376
Mailing Address 25-28 NORTH WALL QUAY DUBLIN L2 DUBLIN 1
Business Address 25-28 NORTH WALL QUAY DUBLIN L2 DUBLIN 1 650-615-2119
Prothena Corp plc (Filer) CIK: 0001559053 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35676 | Film No.: 161801285
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences